<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Although the key role of human homeobox (HOX) genes in development is well established, their function in adult cells is still under scrutiny </plain></SENT>
<SENT sid="1" pm="."><plain>We have analyzed, in <z:mpath ids='MPATH_458'>normal</z:mpath> adult blood cell subpopulations, <z:hpo ids='HP_0006721'>acute lymphoid leukemia</z:hpo> (ALL) cells lines, and primary blasts, the <z:chebi fb="40" ids="33697">RNA</z:chebi> expression of <z:hpo ids='HP_0000001'>all</z:hpo> HOX-2 cluster genes (5'-2.5, 2.4, 2.3, 2.2, 2.1, 2.6, 2.7, 2.8, 2.9, 3') and nine genes in the HOX-1, -3, and -4 cluster by Northern blotting, RNAse protection, and/or reverse transcriptase polymerase chain reaction (RT-PCR) </plain></SENT>
<SENT sid="2" pm="."><plain>The analyzed HOX-1, -3, and -4 genes were never expressed in <z:hpo ids='HP_0000001'>all</z:hpo> tested cell populations </plain></SENT>
<SENT sid="3" pm="."><plain>Natural killer (NK) cells activated in interleukin-2 (IL-2)/IL-1 beta-treated cultures exhibit a gradually increasing, abundant expression of three HOX-2 genes (2.2, 2.6, 2.8), while three other genes (2.3, 2.1, 2.7) are expressed at a lower level at late culture times </plain></SENT>
<SENT sid="4" pm="."><plain>However, no HOX-2 gene is expressed in quiescent lymphocytes (NK, B and T [T-cell receptor (TCR) alpha/beta, gamma/delta lymphocytes, thymocytes] cells), granulocytes, and monocytes </plain></SENT>
<SENT sid="5" pm="."><plain>In B- and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">T-ALL</z:e> cell lines, HOX-2 genes are expressed according to different patterns: (1) widespread transcription (seven of nine genes, including 2.3 and 2.6) in the Peer line bearing the TCR gamma/delta; (2) expression of 2.5, 2.2, and 2.6 in the SEZ 627 line, which derives from an HTLV-1+ T-helper <z:hpo ids='HP_0001909'>leukemia</z:hpo>; (3) transcription of 2.3 and 2.6 in both the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">T-ALL</z:e> CEM line and four <z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B-ALL</z:e> lines (interestingly, CALLA- <z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B-ALL</z:e> lines are constantly 2.3/2.6 RNA+); (4) no HOX-2 gene expression was detected in one T- and two <z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B-ALL</z:e> lines </plain></SENT>
<SENT sid="6" pm="."><plain>Primary blasts from five T- and five <z:e sem="disease" ids="C1292769" disease_type="Neoplastic Process" abbrv="">pre-B-ALL</z:e> showed selective expression of one or more HOX-2 genes, namely 2.5, 2.2, 2.6, and 2.7 </plain></SENT>
<SENT sid="7" pm="."><plain>Our data are compatible with the hypothesis that selected HOX-2 genes play a role in the IL-2/IL-1 beta-induced activation and/or proliferation of <z:mpath ids='MPATH_458'>normal</z:mpath> NK lymphocytes and possibly in the oncogenetic process of some T- and <z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B-ALL</z:e> </plain></SENT>
</text></document>